The Institute of Cancer Research

The Institute of Cancer Research The ICR is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years.

Our mission is to make the discoveries that defeat cancer. The Institute of Cancer Research is making the discoveries that defeat cancer. In addition to being a leading cancer research organisation, we are also a postgraduate college (a member of the University of London), as well as a charity. To make a donation to support our work please visit icr.ac.uk/donate

07/10/2026

What a day! ❤️
Last Sunday, 70 cyclists, including many ICR staff and students joined riders from to support our research into secondary breast cancer.

📍 The cyclist rode 110km starting in the heart of Soho, passing our Chelsea campus, stopping at our Sutton campus outside our Centre for Cancer Drug Discovery, before finishing off with a loop through the Surrey Hills.

We are blown away by the incredible support from One More City, which has already raised more than £500,000 to help drive research into secondary breast cancer.

Among the cyclists who took on the challenge was Professor Andrew Tutt, who shared his thanks to the team. Professor Tutt works alongside Dr Gonzalo Torga, whose research will directly benefit from the funds raised, helping to accelerate progress in this area.

🎉 A huge thank you to every participant and everyone who has donated so generously.

30/09/2026

🎉 This weekend a team of cyclists will take part in the day ride to raise awareness of vital research into secondary breast cancer.

Professor Andrew Tutt, Head of the Breast Cancer Research Division at The Institute of Cancer Research, will be among the cyclists taking part in the 110km ride on Sunday 4 October. The route takes riders from headquarters in Soho, past our labs in Chelsea and our Sutton site, before a loop through the Surrey hills.

It’s not too late to sign up 🚲
Link in bio 🔗

30/09/2026

As we mark the end of Childhood Cancer Awareness Month, we're incredibly thankful for the support from our family charity partners.

Your dedication, commitment, and courage is truly inspiring.

This month has highlighted the incredible progress we’ve made, but also the vital work that still remains.

Hear from Professor Chris Jones, Dr Sally George and Dr Gary Newton as they share their gratitude for the invaluable support of our family charity partners♥️

We’re determined to find innovative treatments that are kinder, smarter, and more effective for childhood cancer.

29/09/2026

We're recruiting patient participants 🚨

The ICR’s SOPRANO trial is investigating whether stereotactic body radiotherapy (SBRT), either on its own or followed by the drug niraparib, can help delay cancer progression and postpone the need for further treatments such as chemotherapy in women with ovarian, fallopian tube, or primary peritoneal cancer.

The study is recruiting up to 42 participants across NHS hospitals in the UK and is aimed at patients whose cancer has started to grow again in a limited number of sites after treatment with a PARP inhibitor.

SOPRANO is currently open at:
✅ The Royal Marsden NHS (Sutton and Chelsea)
✅ The Christie NHS Foundation Trust , Manchester
✅ UCLH - University College London Hospitals NHS Foundation Trust
✅ St James's University Hospital, Leeds
✅ Western General Hospital, Edinburgh
✅ Leicester Royal Infirmary

Learn more about the research behind the trial and how you can get involved ⤵
https://www.icr.ac.uk/research-and-discoveries/centres-and-strategic-collaborations/clinical-trials-and-statistics-unit-icr-ctsu/detail/soprano

29/09/2026

Congratulations to riders who concluded their four-day cycle ride to Montpellier yesterday! 🎉 🚴‍♀️ 🚴‍♂️

The cyclists rode from Nice to raise vital funds towards Dr Gonzalo T.’s breast cancer research.

Last week, Dr Torga and Professor Andrew Tutt, Head of the Breast Cancer Research Division at The Institute of Cancer Research, thanked the riders for their support.

Learn more about One More City and why they support our research. Link in bio 🔗

“I don’t want any family to go through what we have been through” Billy Bloomfield, 28, lost his mum in November 2022, j...
26/09/2026

“I don’t want any family to go through what we have been through”

Billy Bloomfield, 28, lost his mum in November 2022, just three months after she was diagnosed with terminal liver cancer that had spread to her bones.

By the time she was diagnosed, her cancer was too advanced for treatment.

❤ Tomorrow Billy will be running the BERLIN-MARATHON in his mum’s memory, raising funds for our groundbreaking research.

“My mum spent her final months making memories with our family and making sure she had done all she could to ensure everything was in place so we would be looked after when she was gone. Despite being very ill at the time, she was able to do many special things and tick them off her bucket list.

“I’m running the Berlin Marathon to raise money for research that will help find a cure for cancer and better treatment options so that no other family has to go through what my family has been through.”

To support Billy and our vital research, visit Billy's fundraising page ⤵
https://www.justgiving.com/page/billybloomfield?msockid=270d9a84fb5b6c261d938d3ffa0e6d1d

🎽Good luck to Billy and all our runners

If you are interested in fundraising for us next year, register your interest here ⤵
https://www.icr.ac.uk/support-us/fundraising/detail/bmw-berlin-marathon

And they are off!! 🚲A huge good luck to everyone taking part in the One More City Ride, setting off today on an incredib...
24/09/2026

And they are off!! 🚲

A huge good luck to everyone taking part in the One More City Ride, setting off today on an incredible journey from Nice to Montpellier, finishing on Monday 28 September.

We're so grateful to every rider who is taking on this big challenge and fundraising to support our research into secondary breast cancer.

Every donation helps us continue our vital work 👩‍🔬👨‍🔬

See where the riders are in real time and follow their journey using this Live tracker ⤵
https://www.whip.live/event-tracking/OMC26

“Cancer research allows future generations to have hope” ✨Carolyne Hatton, 60, lives in Adelaide, South Australia. She w...
24/09/2026

“Cancer research allows future generations to have hope” ✨

Carolyne Hatton, 60, lives in Adelaide, South Australia. She was diagnosed with invasive lobular breast cancer in September 2024.

Her first two lines of treatment failed, but since October 2025, she has been taking the drug capivasertib, the discovery and development of which was underpinned by research at the ICR. In recent scans her cancer was undetectable.

“I was told my prognosis was anything from three to15 years, but felt reassured that although my cancer wasn’t curable, it was treatable.

“Since starting on capivasertib, I am living better than I have done on any previous medication. It has allowed me to make plans, to travel, to live a normal life, doing everything I want to do.

“Cancer research allows future generations to have hope. Knowing there are people looking into the triggers of cancer and trying to find new treatments is reassuring.

“I feel incredibly special that capivasertib is working so successfully for me. I feel lucky that it is available to me and am blessed that research was done to enable this prize-winning cocktail to exist for me.”

We are proud to be at the forefront of new discoveries that help cancer patients all around the world to live longer, better lives.

Carolyne is sharing her story to mark ⤵
https://www.icr.ac.uk/research-and-discoveries/cancer-blogs/detail/science-talk/since-starting-capivasertib--i-have-hope----carolyne-s-story

This European Head and Neck Cancer Awareness Week, we're highlighting research presented at American Society of Clinical...
23/09/2026

This European Head and Neck Cancer Awareness Week, we're highlighting research presented at American Society of Clinical Oncology (ASCO) earlier this year, which found that a targeted cancer treatment given as a simple injection under the skin could help patients with advanced head and neck cancer who have limited treatment options.

In a clinical trial led by the ICR, the drug amivantamab shrank tumours in 42% of patients whose cancer had stopped responding to standard treatments.

While larger trials are still needed, the findings offer encouraging early evidence of a potential new option for patients.

Head to the link in our comments to read more about the study ⤵

Another fantastic Terry Fox Run UK for The Institute of Cancer Research at Four Seasons Hotel Hampshire, England last Su...
21/09/2026

Another fantastic Terry Fox Run UK for The Institute of Cancer Research at Four Seasons Hotel Hampshire, England last Sunday! ☀️🏃‍♀️🏃‍♂️

With glorious sunshine, stunning grounds and incredible support across the raffle, tombola and auction, it was a day to remember.

A huge thank you to Andrew Harrison, Courtney Cunningham and Diniy D Hamzah for helping make the event such a success, as well as our amazing Terry Fox volunteers whose dedication makes these events possible year after year.

❤ Most importantly, over £7,000 was raised, and every pound will help us continue our vital cancer research. Thanks to the generosity of everyone involved, we can keep driving forward new discoveries and improving outcomes for people affected by cancer.

The Terry Fox Run continues! We're excited for our final two events:

📍 Edinburgh – Sunday 27 September
📍 Wrexham – Sunday 4 October

Sign up ⤵
https://terryfoxrunuk.org/events

We hope to see you there as we come together to honour Terry’s legacy and help defeat cancer.

Address

London

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Telephone

+442073528133

Website

Alerts

Be the first to know and let us send you an email when The Institute of Cancer Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organisation

Send a message to The Institute of Cancer Research:

Shortcuts

Featured

Share

Category